| Typicality: | 0.504 |
| Saliency: | 0.466 |
| with use for undefined durations | 7 | other |
| with approvals for continuous administration | 6 | other |
| to this day | 6 | temporal |
| drug → remain on → the market | 79 |
| drug → stay on → the market | 20 |
| negative | neutral | positive |
| 0.376 | 0.523 | 0.101 |
| Raw frequency | 99 |
| Normalized frequency | 0.466 |
| Modifier score | 0.670 |
| Perplexity | 31.233 |